Evidence map›Paper›PMID 36983384›Full record

ArticleJournal of clinical medicine2023

The Relationship of

Sylwia Popek-Marciniec, Wojciech Styk, Magdalena Wojcierowska-Litwin, Aneta Szudy-Szczyrek, Paul Dudek, Grazyna Swiderska-Kolacz, Joanna Czerwik-Marcinkowska, Szymon Zmorzynski

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Sylwia Popek-MarciniecDepartment of Cancer Genetics with Cytogenetic Laboratory, Medical University of Lublin, 20-059 Lublin, Poland.ORCID 0000-0003-0783-6153
Wojciech StykDepartment of Psychology, Medical University of Lublin, 20-059 Lublin, Poland.ORCID 0000-0003-0186-3118
Magdalena Wojcierowska-LitwinDepartment of Cancer Genetics with Cytogenetic Laboratory, Medical University of Lublin, 20-059 Lublin, Poland.
Aneta Szudy-SzczyrekChair and Department of Hematooncology and Bone Marrow Transplantation, Medical University of Lublin, 20-059 Lublin, Poland.ORCID 0000-0003-2352-394X
Paul DudekDepartment of Cancer Genetics with Cytogenetic Laboratory, Medical University of Lublin, 20-059 Lublin, Poland.
Grazyna Swiderska-KolaczInstitute of Biology, Jan Kochanowski University, 25-406 Kielce, Poland.
Joanna Czerwik-MarcinkowskaInstitute of Biology, Jan Kochanowski University, 25-406 Kielce, Poland.ORCID 0000-0003-2019-7819
Szymon ZmorzynskiDepartment of Cancer Genetics with Cytogenetic Laboratory, Medical University of Lublin, 20-059 Lublin, Poland.
Medical University of Lublin · PLJan Kochanowski University · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

(1) Background: Chemokines and chemokine receptors play an important role in tumor development. The aim of this study was to check the significance of

Indexed as

CCL5 geneCCR1 genechemokine receptorschemokinesgenetic variantsmultiple myelomapolymorphisms

Identifiers

PMID36983384
PMCPMC10056693
OpenAlexW4327960057

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.